<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129594">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02104076</url>
  </required_header>
  <id_info>
    <org_study_id>10-014</org_study_id>
    <nct_id>NCT02104076</nct_id>
  </id_info>
  <brief_title>Evolution® Biliary Stent System-Fully Covered</brief_title>
  <official_title>Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Canada: Health Canada</authority>
    <authority>European Union: European Medicines Agency</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the
      US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered
      when used in palliation of malignant neoplasms in the biliary tree.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Percentage of patients free from symptomatic recurrent of biliary obstruction requiring reintervention</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Carcinomas/Neoplasms</condition>
  <arm_group>
    <arm_group_label>Evolution® Biliary Stent-Fully  Covered</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Evolution® Biliary Stent-Fully  Covered</intervention_name>
    <description>Implantation of the Evolution® Biliary Stent-Fully Covered in the common bile duct utilizing ERCP</description>
    <arm_group_label>Evolution® Biliary Stent-Fully  Covered</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inoperable malignant neoplasm causing biliary obstruction or stricture that
             requires a fully covered metal stent

        Exclusion Criteria:

          -  &lt; 18 years of age

          -  Unwilling or unable to sign and date the informed consent

          -  Unwilling or unable to comply with the follow-up schedule

          -  Undergone or is planning to undergo brachytherapy with transpapillary or percutaneous
             implantation of intracavitary radiation sources

          -  Participating in another investigational drug or device study in which patient has
             not completed the follow-up phase for the primary endpoint at least 30 days prior to
             enrollment

          -  Endoscopic procedures are contraindicated

          -  Current anatomy upstream of intended stent placement compromising the flow of bile
             from the liver such that stent placement may not alleviate the biliary obstruction
             symptoms

          -  Presence of a metal biliary stent

          -  Presence of an esophageal or duodenal stent

          -  Hypersensitivity/allergy or contraindication to any component of the stent, delivery
             system, or medication required to complete the procedure,which in the investigator's
             opinion cannot be adequately premedicated

          -  Coagulopathy

          -  Diffuse intrahepatic metastases that involves &gt; 10 % of the liver

          -  Life expectancy of &lt; 3 months

          -  Pregnant

          -  Active alcohol or substance abuse issue

          -  Jaundice secondary to a cause other than biliary duct obstruction

          -  Additional endoscopic restrictions as specified in the Clinical Investigation Plan
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raj Shah, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Bruno, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus Medish Centrum</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Travis Conley, PhD</last_name>
    <phone>765-463-7537</phone>
    <email>tconley@medinst.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Malin Tygesen</last_name>
    <phone>+45 56868572</phone>
    <email>Malin.Tygesen@CookMedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lindsay Hosford</last_name>
      <email>Lindsay.hosford@UCdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Raj Shah, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Jason Klapman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Lee McHenry, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ram Chuttani, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>John Evans, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Adam Slivka, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Gary May, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de 1'Université</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andre Roy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon Cedex 03</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Thierry Ponchon, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Paoli-Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marc Giovannini, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital L'Archet 2</name>
      <address>
        <city>Nice Cedex 03</city>
        <zip>23079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Geoffroy Vanbiervliet, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Bellaria-Maggiore</name>
      <address>
        <city>Bologna</city>
        <zip>40139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Vincenzo Cennamo, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus Medish Centrum</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marco Bruno, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Canada</country>
    <country>France</country>
    <country>Italy</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>April 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bile Duct Obstructions</keyword>
  <keyword>Biliary Stases</keyword>
  <keyword>Biliary Tract</keyword>
  <keyword>Stents</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
